Previous 10 | Next 10 |
2023-12-12 13:00:16 ET Summary Gilead Sciences, Inc. had strong quarterly results, with total product sales of $6.3 billion and strong growth in HIV and Oncology. The company has several milestones, including the success of Trodelvy with over $1 billion in annualized sales. Gi...
2023-12-12 02:25:00 ET Summary The S&P 500 registered its best month in nearly a year and a half, but still could not keep pace with the Moat Index in November. The Moat Index has now outpaced the S&P 500 by nearly 200 bps for the year, with one month to go. The Mornin...
– ZUMA-1 Post-Hoc Analysis Shows Five-Year Lymphoma-Related Event-Free Survival in a Substantial Proportion of Patients with Refractory Large B-cell Lymphoma – – Four-Year Follow-up from ZUMA-5 Demonstrates Continued Durable Response and Long-Term Survival in Pati...
– At Almost Four Years of Follow-up in the Pivotal ZUMA-2 Study, Median Overall Survival was 46.4 Months, Supporting Long-Term Response in Adult Patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) – – Real-World Evidence (RWE) Shows Effectiveness in...
– First Ever Prospective Phase 2 Study to Evaluate CAR T-Cell Therapy as First-Line Therapy Reads Out Three-Year Follow-Up Analysis – – At Median Follow-Up of 40.9 Months, Patients Treated with Yescarta ® Experienced an 86% Complete Response Rate and the ...
– Gilead Also Included on the Dow Jones Sustainability North America Index; Rankings Reflect Gilead’s Ongoing Commitment to Corporate Responsibility – – DJSI World Highlights the Most Sustainable Companies Around the World Based on Corporate...
2023-12-10 13:48:00 ET On Nov. 28, the Food and Drug Administration (FDA) announced that it was opening an investigation into the possibility of previously unknown serious safety risks associated with the hottest and most technological group of cancer medicines produced to date. Now, drugma...
2023-12-10 08:22:39 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-12-07 14:25:11 ET Summary Korn Ferry, Gilead Sciences, Qualcomm, Ralph Lauren, and Manpower are identified as five companies with high dividend yields and strong capacity for future dividend increases. Korn Ferry is a leader in leadership and talent consulting services with s...
2023-12-06 13:16:08 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
News, Short Squeeze, Breakout and More Instantly...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2024 financial results and guidance will be released on Thursday, August 8, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’...
– New 5-Year Clinical and Real-World Data Reinforce Biktarvy ® as a Long-Term Treatment Option for a Diverse Range of People with HIV, Including Those with Comorbidities – – Investigational, Once-Daily, Once-Weekly and Twice-Yearly Dosing Frequenc...
– PURPOSE 1 Data Showed Zero Infections and 100% Efficacy and Superiority of Lenacapavir to Background HIV Incidence and Daily Truvada ® for PrEP – – If Approved, Lenacapavir Would be the First and Only Twice-Yearly PrEP Choice and Could Address C...